In E03, we conclude our discussion of depression by unpacking the three main societal beneficiaries of a biomedical construction of MDD: psychiatrists, the pharmaceutical industry, and society's ruling class.
In E03, we conclude our discussion of depression by unpacking the three main societal beneficiaries of a biomedical construction of MDD: psychiatrists, the pharmaceutical industry, and society's ruling class.